Article
Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms in Children with Pitt-Hopkins Syndrome: A Randomized Clinical Trial
2026-07-15
Abstract excerpt
<title>Abstract</title> <p> Pitt-Hopkins syndrome (PTHS) is an ultrarare neurodevelopmental disorder caused by <italic>TCF4</italic> gene mutations and frequently accompanied by severe gastrointestinal (GI) dysfunction, suggesting disruption of the gut-brain axis. We conducted a randomized, double-blind, placebo-controlled trial with open-label extension to evaluate microbiota transplant therapy (MTT) in seven...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e0a734e9-3d4d-5de1-8431-d504753027a2
- DOI
- 10.21203/rs.3.rs-9930475/v1
